AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Argent BioPharma Limited

0.115

+0.000

Volume:18.51K

Turnover:2.12K

Market Cap:8.30M

PE:-0.26

High:0.115

Open:0.110

Low:0.110

Close:0.115

Loading ...

Overview Company News Filings

Argent Biopharma - Hy Net Loss Attributable a$12.2 Mln

THOMSON REUTERS

Argent Biopharma Ltd. Updates on Sintef Collaboration for Chronic Wound Management

THOMSON REUTERS

Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

Sparc fires up following three-way hydrogen tie-in

The Sydney Morning Herald

Argent BioPharma Completes $4.5 Million Placement; Shares Up 47%

MT Newswires Live

BUZZ-Australia's Argent BioPharma rises most in over 3 months on premium capital raising

Argent Biopharma Ltd. Placing to Raise US$4,500,000

THOMSON REUTERS

Argent BioPharma Files Trading Halt Ahead of Capital Raise

MT Newswires Live

BRIEF-Argent Biopharma Seeks Trading Halt

Argent Biopharma Ltd Seeks Trading Halt Pending Announcement on Capital Raising

THOMSON REUTERS

Argent BioPharma to Delist From London Stock Exchange, Mulls U.S. Listing

BRIEF-Argent Biopharma Ltd To Delist from London Stock Exchange

Argent Biopharma Ltd: Will Maintain Its Listings on ASX and Otcqb Venture Market

THOMSON REUTERS

Argent Biopharma Ltd: Notice of Intention to Delist From London Stock Exchange

THOMSON REUTERS

Argent Biopharma Ltd - ASX & Lse Listing Update

THOMSON REUTERS

BRIEF-Argent Biopharma Announces Intention To Delist From London Stock Exchange

Argent Biopharma Ltd - Notice of Intention to Delist From London Stock Exchange

THOMSON REUTERS

Argent Biopharma Ltd - Decided to Retain Its Listing on ASX

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RGT.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RGT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","market":"AU","secType":"STK","nameCN":"Argent BioPharma Limited","latestPrice":0.115,"timestamp":1746771120000,"preClose":0.115,"halted":0,"volume":18510,"delay":0,"nameEN":"Argent BioPharma Limited","floatShares":14793190,"shares":72183153,"eps":-0.44518,"marketStatus":"Not Yet Opened","change":0,"latestTime":"05-09 16:12:00 AEST","open":0.11,"high":0.115,"low":0.11,"amount":2121,"amplitude":0.043478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.44518,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1747008000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.115,"openAndCloseTimeList":[[1746748800000,1746770400000]],"volumeRatio":0.6845464792813764,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","floatShares":14793190,"roa":"-121.60%","roe":"--","lyrEps":-0.47364,"volumeRatio":0.6845464792813764,"shares":72183153,"dividePrice":0,"high":0.115,"amplitude":0.043478,"preClose":0.115,"low":0.11,"week52Low":0.11,"pbRate":"-0.76","psRate":"28.06","week52High":0.57,"institutionHeld":0,"latestPrice":0.115,"eps":-0.44518,"divideRate":0,"volume":18510,"delay":0,"ttmEps":-0.44518,"open":0.11,"prevYearClose":0.17,"prevWeekClose":0.115,"prevMonthClose":0.13,"prevQuarterClose":0.17,"fiveDayClose":0.13,"twentyDayClose":0.18,"sixtyDayClose":0.125},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RGT.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514995063","title":"Argent Biopharma - Hy Net Loss Attributable a$12.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514995063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514995063?lang=en_us&edition=fundamental","pubTime":"2025-02-28 13:17","pubTimestamp":1740719839,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PI2I6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU"],"gpt_icon":0},{"id":"2511536038","title":"Argent Biopharma Ltd. Updates on Sintef Collaboration for Chronic Wound Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2511536038","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511536038?lang=en_us&edition=fundamental","pubTime":"2025-02-13 06:30","pubTimestamp":1739399402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nTUA9PCBSM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2511253997","title":"Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2511253997","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511253997?lang=en_us&edition=fundamental","pubTime":"2025-02-13 06:30","pubTimestamp":1739399400,"startTime":"0","endTime":"0","summary":"Advanced wound care market projected to exceed $15 billion globally by 2030. PERTH, Australia, Feb. 12, 2025 /PRNewswire/ -- Argent BioPharma Ltd.   has made significant progress in its collaboration with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care. The project leverages nano-encapsulation technology to improve drug efficacy and targeted delivery.SINTEF, headquartered in Trondheim, Norway, is an independent research organization founded in 1950 that conducts contract research and development projects.Optimizing Antimicrobial Compounds: The company has advanced its proprietary antimicrobial compounds for nano-encapsulation, improving their targeted drug delivery.Key Research Milestones Achieved: Standardized in vitro assays have been established, Synthetic Wound Fluid  identified as the optimal testing medium, and promising active pharmaceutical ingredients  with pH-dependent antimicrobial activity selected.In the project's first phase","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/argent-biopharma-ltd-updates-sintef-223000107.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/argent-biopharma-ltd-updates-sintef-223000107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7054","BK7096","BK7503","RGTLF","SWF.AU","BK4007","RGT.AU"],"gpt_icon":0},{"id":"2509537251","title":"Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2509537251","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509537251?lang=en_us&edition=fundamental","pubTime":"2025-02-06 05:00","pubTimestamp":1738789200,"startTime":"0","endTime":"0","summary":"For thousands of patients with refractory epilepsy—commonly referred to as drug-resistant epilepsy—the search for effective treatment often feels like navigating an endless maze. These individuals, about 30% of the epilepsy community, live with seizures that persist despite conventional therapies. Now, a groundbreaking solution, CannEpil, is offering hope.Developed by Argent BioPharma Limited, CannEpilis an oral mucosal solution with a high-CBD, low-THC formulation. It is designed to reduce seizure frequency and severity while minimizing psychoactive effects. After years of clinical development, CannEpilis making waves in the UK as part of a movement to transform severe epilepsy treatment.This breakthrough follows GW Pharmaceuticals' $7.2 billion acquisition, highlighting the potential of cannabis-based epilepsy treatments. Argent BioPharma's CannEpilis poised to follow a similar trajectory, offering a novel solution for drug-resistant epilepsy patients worldwide.Additionally, CannEpil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/argent-biopharma-hidden-gem-traded-210000855.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/argent-biopharma-hidden-gem-traded-210000855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["RGT.AU","EIX"],"gpt_icon":0},{"id":"2502839668","title":"Sparc fires up following three-way hydrogen tie-in","url":"https://stock-news.laohu8.com/highlight/detail?id=2502839668","media":"The Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502839668?lang=en_us&edition=fundamental","pubTime":"2025-01-10 14:09","pubTimestamp":1736489340,"startTime":"0","endTime":"0","summary":"This week the market again encountered a diverse mix of high-flying winners, with those finding favour on the market comprising a new-age hydrogen tech developer, an immune-related disorder biopharma firm, a mining company growing its scandium critical mineral resource and a drug developer joining forces with a Japanese pharmaceutical firm to fight kidney disease.This week’s Bulls N’ Bears ASX Runner of the Week is…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/sparc-fires-up-following-three-way-hydrogen-tie-in-20250110-p5l3fv.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["BK7096","BK7036","BK7508","AUZ.AU","RGT.AU","BK7501","BK7095","BK7067","BK7504","SPN.AU","DXB.AU"],"gpt_icon":0},{"id":"2501243960","title":"Argent BioPharma Completes $4.5 Million Placement; Shares Up 47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501243960","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501243960?lang=en_us&edition=fundamental","pubTime":"2025-01-07 12:09","pubTimestamp":1736222945,"startTime":"0","endTime":"0","summary":"Argent BioPharma (ASX:RGT) completed a $4.5 million placement via the subscription of about 11.3 million fully paid ordinary shares at $0.40 per share, according to a Tuesday Australian bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2501212358","title":"BUZZ-Australia's Argent BioPharma rises most in over 3 months on premium capital raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2501212358","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501212358?lang=en_us&edition=fundamental","pubTime":"2025-01-07 10:50","pubTimestamp":1736218201,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Argent BioPharma rises most in over 3 months on premium capital raising ** Shares of Argent BioPharma RGT.AX rise as much as 52.9% to A$0.260, their biggest intraday pct gain since Oct 1, 2024** The clinical-stage biopharma co completes $4.5 mln capital raise at $0.40 per share** Issue price represents a premium of 276.5%, compared with stock's last closing price of A$0.17** Says placement will help advance co's drug development pipeline, with focus on clinical studies for CannEpil - a seizure-control treatment for refractory epilepsy and cerebral palsy** Stock hits its highest level since Dec 2** About 231,485 shares change hands, 13.2 times the 30-day average volume of 17,562 ** Stock fell 64.2% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nL4N3O305G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","RGT.AU"],"gpt_icon":0},{"id":"2501261223","title":"Argent Biopharma Ltd. Placing to Raise US$4,500,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2501261223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501261223?lang=en_us&edition=fundamental","pubTime":"2025-01-07 04:00","pubTimestamp":1736193613,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nFWN3O22H6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2500747136","title":"Argent BioPharma Files Trading Halt Ahead of Capital Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2500747136","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500747136?lang=en_us&edition=fundamental","pubTime":"2025-01-03 10:23","pubTimestamp":1735871009,"startTime":"0","endTime":"0","summary":"Argent BioPharma  requested a trading halt for its shares pending a disclosure to be made by the company regarding a capital raise, according to a Friday filing with the Australian bourse.The shares will remain in a trading halt until the announcement is made or the start of normal trading on Jan. 7 or upon the release of the disclosure, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2500184015","title":"BRIEF-Argent Biopharma Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2500184015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500184015?lang=en_us&edition=fundamental","pubTime":"2025-01-03 08:33","pubTimestamp":1735864383,"startTime":"0","endTime":"0","summary":"Jan 3 (Reuters) - Argent BioPharma Ltd   :   * SEEKS TRADING HALT PENDING ANNOUNCEMENT ON  CAPITAL RAISING   * SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL RAISINGFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","RGT.AU"],"gpt_icon":0},{"id":"2500838291","title":"Argent Biopharma Ltd Seeks Trading Halt Pending Announcement on Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2500838291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500838291?lang=en_us&edition=fundamental","pubTime":"2025-01-03 06:34","pubTimestamp":1735857270,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250102:nFWN3NY0S6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2487527584","title":"Argent BioPharma to Delist From London Stock Exchange, Mulls U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2487527584","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487527584?lang=en_us&edition=fundamental","pubTime":"2024-11-29 15:57","pubTimestamp":1732867020,"startTime":"0","endTime":"0","summary":"Argent BioPharma said it plans to leave the London Stock Exchange while mulling a listing in the U.S.The pharmaceutical company, which will keep its stock-market listing in Australia, said it has taken steps to cancel the admission of its shares on the LSE.The decision followed a review of both the listing requirements and costs associated with the transfer of all its ordinary shares, it said Friday.Argent Biopharma expects the last day of trading on the LSE to be Dec. 31.The company said it might still look to explore opportunities to expand its accessibility to investors, including a potential listing on an U.S. exchange.The company's main operations and management are based in the EU, with a growing investor base in the U.S.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2487585974","title":"BRIEF-Argent Biopharma Ltd To Delist from London Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2487585974","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487585974?lang=en_us&edition=fundamental","pubTime":"2024-11-29 15:05","pubTimestamp":1732863958,"startTime":"0","endTime":"0","summary":"BRIEF-Argent Biopharma Ltd To Delist from London Stock ExchangeNov 29 (Reuters) - London Stock Exchange Group PLC LSEG.L:ARGENT BIOPHARMA LTD  - ASX & LSE LISTING UPDATEARGENT BIOPHARMA LTD: NOTICE OF","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nTUC1HTFZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0887340254.USD","LU2023251221.USD","LU0526926950.USD","IE00BQXX3F31.USD","LU1355424745.HKD","LU2111349929.HKD","IE00BQXX3D17.EUR","LU2028103732.USD","LU0472753341.HKD","LU0069063385.USD","LU2271345857.HKD","LU0289739343.SGD","IE00BKPKM643.USD","LU0289961442.SGD","LU0171280430.USD","LU0788108743.HKD","LU2089284900.SGD","LU0158827781.USD","IE00BQXX3C00.GBP","LU0175139822.USD","LSEG.UK","LU1228905037.USD","LU0511384066.AUD","LU1228905540.USD","BK7096","LU0171276677.USD","LU0963555726.SGD","RGT.AU","LU0289960550.SGD","LU2089283258.USD","LU0158827948.USD","LU0171293334.USD","LU0969580561.USD","LU0057025933.USD","LU0545562505.USD","BK5051"],"gpt_icon":0},{"id":"2487855415","title":"Argent Biopharma Ltd: Will Maintain Its Listings on ASX and Otcqb Venture Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2487855415","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487855415?lang=en_us&edition=fundamental","pubTime":"2024-11-29 15:00","pubTimestamp":1732863606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nTUC1HTFZQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU"],"gpt_icon":0},{"id":"2487855145","title":"Argent Biopharma Ltd: Notice of Intention to Delist From London Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2487855145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487855145?lang=en_us&edition=fundamental","pubTime":"2024-11-29 15:00","pubTimestamp":1732863606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nTUC1HTFZQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2487585549","title":"Argent Biopharma Ltd  - ASX & Lse Listing Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2487585549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487585549?lang=en_us&edition=fundamental","pubTime":"2024-11-29 15:00","pubTimestamp":1732863606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nTUC1HTFZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BQXX3F31.USD","LU0175139822.USD","LU0472753341.HKD","LU2023251221.USD","BK5051","LU0069063385.USD","LU0289739343.SGD","IE00BQXX3D17.EUR","LU1228905540.USD","BK7096","LU0171276677.USD","RGT.AU","LSEG.UK","LU1355424745.HKD","LU2089284900.SGD","IE00BQXX3C00.GBP","LU0788108743.HKD","LU0158827781.USD","LU0963555726.SGD","LU0511384066.AUD","LU0171280430.USD","LU0057025933.USD","LU0289961442.SGD","LU2111349929.HKD","LU0171293334.USD","LU0158827948.USD","LU0969580561.USD","LU2028103732.USD","LU2271345857.HKD","LU2089283258.USD","LU0289960550.SGD","IE00BKPKM643.USD","LU0545562505.USD","LU0526926950.USD","LU0887340254.USD","LU1228905037.USD"],"gpt_icon":0},{"id":"2487274343","title":"BRIEF-Argent Biopharma Announces Intention To Delist From London Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2487274343","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487274343?lang=en_us&edition=fundamental","pubTime":"2024-11-29 07:50","pubTimestamp":1732837847,"startTime":"0","endTime":"0","summary":"BRIEF-Argent Biopharma Announces Intention To Delist From London Stock ExchangeNov 29 (Reuters) - Argent BioPharma Ltd RGT.AX:NOTICE OF INTENTION TO DELIST FROM LONDON STOCK EXCHANGEDECIDED TO RETAIN ITS LISTING ON ASXFurther company coverage: RGT.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241128:nFWN3MZ0DN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2487532436","title":"Argent Biopharma Ltd - Notice of Intention to Delist From London Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2487532436","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487532436?lang=en_us&edition=fundamental","pubTime":"2024-11-29 06:58","pubTimestamp":1732834737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241128:nFWN3MZ0DN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGT.AU","BK7096"],"gpt_icon":0},{"id":"2487324369","title":"Argent Biopharma Ltd - Decided to Retain Its Listing on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2487324369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487324369?lang=en_us&edition=fundamental","pubTime":"2024-11-29 06:58","pubTimestamp":1732834737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241128:nFWN3MZ0DN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RGT.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-09-23","symbol":"RGT.AU","reason":null,"defaultRemindTime":1727049600000,"announcedDate":"2024-08-15","type":"delisting","dateTimestamp":1727013600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGT.AU\",market:\"AU\",,,undefined,":[]}}